If you wish to report an adverse event or product complaint, please call 1-800-LILLYRX(1-800-545-5979)
Mounjaro™ (tirzepatide) injection2.5 mg/5 mg/7.5 mg/10 mg/12.5 mg/15 mg
This information is provided in response to your request. Resources may contain information about doses, uses, formulations and populations different from product labeling. See Prescribing Information above, if applicable.
Tirzepatide: Use in Patients With T1DM
Tirzepatide has not been studied in people with type 1 diabetes.
There is no information on the use of tirzepatide in people with T1DM because patients with T1DM were excluded from tirzepatide clinical trials. At this time, we do not have plans to conduct tirzepatide clinical trials in people with T1DM.
T1DM = type 1 diabetes mellitus
Date of Last Review: March 02, 2021